IHS Chemical Week

Pharma/fine chemicals roundup—25 October 2016

October 25, 2016 | By DEEPTI RAMESH

Ashland opens pharmaceutical excipient production facility in China Ashland says it has opened a new pharmaceutical excipient production facility at Nanjing, China. Demand for polymer excipients, the substances formulated alongside the active ingredients of medications, is rising in China as the country’s pharmaceutical industry moves to modernize oral drug manufacturing and comply with new quality...

Pharma/fine chemicals roundup—18 October 2016

October 18, 2016 | By DEEPTI RAMESH

CPhI Worldwide: Trends in Pharma CMOs, CDMOs, and biosimilars to continue generating growth The continuing development and consolidation of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) and the rapid growth of biosimilars and antibody-drug conjugates (ADCs), were some of the main topics of conversation among attendees at the CPhI Worldwide...

Pharma/fine chemicals roundup—4 October 2016

October 4, 2016 | By DEEPTI RAMESH

CPhI Barcelona: The challenges associated with outsourcing manufacturing The use of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) continues to be a source of discussion in the pharmaceutical industry, according to exchanges at CPhI, being held this week in Barcelona. The industry, in particular the larger pharmaceutical companies that make much...

Pharma/fine chemicals roundup—20 September 2016

September 20, 2016 | By DEEPTI RAMESH

Novasep and US-based Triclinic Labs form alliance for solid-state chemistry services Novasep (Lyon, France), a supplier of services and technologies for the life sciences industry, has formed a partnership with Triclinic Labs (Lafayette, Indiana), a provider of contract pharmaceutical and fine chemical solid-state development services. The alliance between Novasep and Triclinic Labs will enable both...

Pharma/fine chemicals roundup—13 September 2016

September 13, 2016 | By DEEPTI RAMESH

Cambrex to expand large-scale, multi-purpose manufacturing capabilities in Sweden Cambrex (East Rutherford, New Jersey), a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), says that it will invest approximately $9 million to expand large-scale manufacturing capacity at its Karlskoga, Sweden facility. The investment includes the installation of new multi-purpose...

Pharma/fine chemicals roundup—6 September 2016

September 6, 2016 | By DEEPTI RAMESH

SOCMA's BPTF concludes negotiations for round two of Generic Drug User Fee program The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), has ended negotiations for the reauthorization of the US Food and Drug Administration's (FDA) Generic Drug User Fee (GDUFA) program. BPTF is a longtime stakeholder in the GDUFA program, which is designed...

ACC's specialty chemicals market volume decreases while adhesives, flavors and fragrances markets improve

September 2, 2016 | By MICHAEL RAVENSCROFT

American Chemistry Council's (ACC) specialty chemicals market volume index declined 0.9% in July 2016, measured on a three-month moving average, compared with the year-ago month but gained 0.2% on the previous month. Nevertheless, of the 28 sectors ACC tracks, 17 improved year over year (YOY), with the big winner being adhesives and sealants, which improved 10% YOY. The losers continue to be led by...

Pharma/fine chemicals roundup—30 August 2016

August 30, 2016 | By DEEPTI RAMESH

FDA issues warning letters to API plants in China and India The US FDA issued a warning letter on 12 August 2016 to the active pharmaceutical ingredient (API) manufacturing facilities of Unimark Remedies Ltd., located at Vapi and at Bavla, in India; and a separate warning letter on 4 August 2016 to the API facility of Zhejiang Medicine Co. Ltd., located in Xinchang, China—for violating cGMP. Separate...

Analysis: ChemChina-Syngenta merger receives clearance, Texas commission settles Westlake-Eastman pipeline dispute

August 26, 2016 | By JING CHEN

While China National Chemical Corp. (ChemChina) and Syngenta received clearance last week from the Committee on Foreign Investment in the United States (CFIUS) to move forward with the companies’ proposed $43-billion merger, the Senate Judiciary Committee will hold a hearing on increasing consolidation within seeds and agchems in late September.  Sen. Chuck Grassley (R., IA), also a chairman in...

Pharma/fine chemicals roundup—23 August 2016

August 23, 2016 | By DEEPTI RAMESH

Piramal to acquire US HPAPI manufacturer Ash Stevens for $42.95 million Piramal Enterprises Ltd. (Mumbai) has agreed to acquire Ash Stevens Inc. (Riverview, Michigan), a pharmaceutical contract development and manufacturing organization (CDMO), for $42.95 million in cash and an earn-out consideration of up to $10 million. Piramal expects to complete the deal by the end of August. Ash Stevens operates a...


Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact rob.westervelt@ihs.com.

RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa